125 related articles for article (PubMed ID: 965083)
1. [Effect of canrenoate potassium on intraoperative disturbances of electrolyte equilibrium].
Eschner J; Fodor L; Ahnefeld FW
Infusionsther Klin Ernahr; 1976 Apr; 3(2):98-104. PubMed ID: 965083
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
Matsuda K; Tatsuta N; Konishi Y; Minami K; Nishiwaki N; Yamasato A; Chiba Y; Ishihara H; Murata S; Shiraishi Y; Muraguchi T; Hikasa Y
Nihon Geka Hokan; 1982 May; 51(3):519-27. PubMed ID: 7138201
[No Abstract] [Full Text] [Related]
3. [Use of potassium canrenoate in cardiosurgery].
Tufano R; Scopa M; Brando G; Leone D
Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Coltorti M; Radaeli E; Ciaccio S; Corsini R; Trebbi R
Clin Ter; 1976 Feb; 76(3):215-34. PubMed ID: 963962
[No Abstract] [Full Text] [Related]
5. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
Ruggerini R; Mazzocchi F; Albini G; Cifalinò M
Minerva Anestesiol; 1979 Sep; 45(9):687-90. PubMed ID: 117400
[TBL] [Abstract][Full Text] [Related]
6. [Use of an aldosterone antagonist in abdominal surgery].
Ribero F; Remonda G; Morachioli N; Pugnani M
Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
[TBL] [Abstract][Full Text] [Related]
7. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study.
Polderman KH; Girbes AR
Crit Care; 2004 Dec; 8(6):R459-66. PubMed ID: 15566592
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
Capuani A; Bernabei M; Pasque A; Eufrate S
G Ital Cardiol; 1980; 10(9):1148-55. PubMed ID: 7461364
[TBL] [Abstract][Full Text] [Related]
9. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
Denis B; Machecourt J; Denis MC; Morena H; Pellet J; Rossignol B; Martin-Noël P
Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1014-22. PubMed ID: 116612
[TBL] [Abstract][Full Text] [Related]
10. [Value of Soludactone in cardiac surgery in adults].
Fogliani J; Capuccio P; Goudard A; Guillen JC; Monties JR
Ann Anesthesiol Fr; 1975; 16(3):189-96. PubMed ID: 241276
[TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
Costa FV; Borghi C; Mussi A; Ambrosioni E
Minerva Cardioangiol; 1988 Oct; 36(10):503-7. PubMed ID: 3226562
[No Abstract] [Full Text] [Related]
12. [Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
Kuntz E
MMW Munch Med Wochenschr; 1982 May; 124(19):465-7. PubMed ID: 6810108
[No Abstract] [Full Text] [Related]
13. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
Emili M; Cuppone R; Ricci GL
Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
[TBL] [Abstract][Full Text] [Related]
14. [Potassium canreonate in neurosurgical brain edema].
Mille T; Rodriguez R; Baena Y
Minerva Chir; 1975 Jul 15-31; 30(13-14):781-9. PubMed ID: 1221307
[TBL] [Abstract][Full Text] [Related]
15. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
[No Abstract] [Full Text] [Related]
16. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
Tartagni F; Pasetti L; Ambrosioni E; Magnani B
G Clin Med; 1979 Mar; 60(3):196-206. PubMed ID: 520727
[No Abstract] [Full Text] [Related]
17. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C
Med Interne; 1977; 15(1):27-34. PubMed ID: 841250
[TBL] [Abstract][Full Text] [Related]
18. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
Waldorff S; Buch J
Eur J Cardiol; 1979 Aug; 10(2):143-9. PubMed ID: 477703
[TBL] [Abstract][Full Text] [Related]
19. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
[No Abstract] [Full Text] [Related]
20. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
Traina M; Vizzini GB
Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
